KZR
Closed
Kezar Life Sciences Inc
4.4
-0.2 (-4.37%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.58
Day's Range: 4.4 - 4.62
Send
sign up or login to leave a comment!
When Written:
2.51
Kezar Life Sciences Inc is a clinical-stage biotechnology company that is focused on the development of novel immunology therapies for the treatment of autoimmune diseases and cancer. The company's lead product candidate, KZR-616, is a selective immunoproteasome inhibitor that is being developed for the treatment of systemic lupus erythematosus (SLE), lupus nephritis (LN), and other autoimmune diseases. Kezar is also developing other product candidates that target different components of the immune system, including cytokines and T-cell receptors. The company was founded in 2015 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








